CJASN:蛋白尿与糖尿病患者认知减退相关

2013-09-24 佚名 医学论坛网

美国一项研究表明,在肾小球滤过率(eGFR)正常的糖尿病患者中,持续性和进展性蛋白尿与认知功能减退具有相关性。论文近日在线发表于《美国肾脏病学会临床杂志》(Clin J Am Soc Nephrol)。 此项研究共纳入2977例基线eGFR正常的糖尿病患者(平均年龄62.5±5.8),并在基线、20和40个月时对其实施神经心理学测验。测验内容包括信息处理速度、词语记忆和执行功能。利用混合效应模型

美国一项研究表明,在肾小球滤过率(eGFR)正常的糖尿病患者中,持续性和进展性蛋白尿与认知功能减退具有相关性。论文近日在线发表于《美国肾脏病学会临床杂志》(Clin J Am Soc Nephrol)。

此项研究共纳入2977例基线eGFR正常的糖尿病患者(平均年龄62.5±5.8),并在基线、20和40个月时对其实施神经心理学测验。测验内容包括信息处理速度、词语记忆和执行功能。利用混合效应模型评估蛋白尿和eGFR与认知减退百分比的相关性。平均随访时间为3.3年。

结果显示,与基线和随访时均无蛋白尿的受试者相比,基线和随访时均伴蛋白尿(持续性蛋白尿)以及基线无蛋白尿但随访时出现(进展性蛋白尿)的受试者均表现为信息处理速度减退百分比增大(P=0.001和0.10)。词语记忆测验相应呈交界性百分比变化(P=0.11和0.08)。在Logistic回归分析中,持续性和进展性蛋白尿与信息处理速度减退≥5%具有相关性,但与词语记忆和执行功能无关。eGFR每年减退1 ml/min/1.73 m2与认知功能减退呈交界相关。

原文阅读

Barzilay JI, Lovato JF, Murray AM, Williamson J, Ismail-Beigi F, Karl D, Papademetriou V, Launer LJ.Albuminuria and Cognitive Decline in People with Diabetes and Normal Renal Function.Clin J Am Soc Nephrol. 2013 Aug 29.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1954717, encodeId=32071954e17bc, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Jun 07 20:56:00 CST 2014, time=2014-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783226, encodeId=f71d1e83226b3, content=<a href='/topic/show?id=2f7d4e816b' target=_blank style='color:#2F92EE;'>#CJASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4781, encryptionId=2f7d4e816b, topicName=CJASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Mar 22 10:56:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941239, encodeId=1ceb1941239c1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Aug 16 10:56:00 CST 2014, time=2014-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473747, encodeId=c78d14e3747d4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Sep 26 00:56:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1954717, encodeId=32071954e17bc, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Jun 07 20:56:00 CST 2014, time=2014-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783226, encodeId=f71d1e83226b3, content=<a href='/topic/show?id=2f7d4e816b' target=_blank style='color:#2F92EE;'>#CJASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4781, encryptionId=2f7d4e816b, topicName=CJASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Mar 22 10:56:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941239, encodeId=1ceb1941239c1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Aug 16 10:56:00 CST 2014, time=2014-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473747, encodeId=c78d14e3747d4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Sep 26 00:56:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
    2014-03-22 ay2000fy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1954717, encodeId=32071954e17bc, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Jun 07 20:56:00 CST 2014, time=2014-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783226, encodeId=f71d1e83226b3, content=<a href='/topic/show?id=2f7d4e816b' target=_blank style='color:#2F92EE;'>#CJASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4781, encryptionId=2f7d4e816b, topicName=CJASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Mar 22 10:56:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941239, encodeId=1ceb1941239c1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Aug 16 10:56:00 CST 2014, time=2014-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473747, encodeId=c78d14e3747d4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Sep 26 00:56:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
    2014-08-16 chenhongpeng
  4. [GetPortalCommentsPageByObjectIdResponse(id=1954717, encodeId=32071954e17bc, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Jun 07 20:56:00 CST 2014, time=2014-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783226, encodeId=f71d1e83226b3, content=<a href='/topic/show?id=2f7d4e816b' target=_blank style='color:#2F92EE;'>#CJASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4781, encryptionId=2f7d4e816b, topicName=CJASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Mar 22 10:56:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941239, encodeId=1ceb1941239c1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Aug 16 10:56:00 CST 2014, time=2014-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473747, encodeId=c78d14e3747d4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Sep 26 00:56:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]

相关资讯

单次测量基线蛋白尿易低估肾脏不良预后风险

    加拿大阿尔伯塔大学医院的Aminu Bello博士在《美国肾脏病杂志》(Am J Kidney Dis. 2012 Mar;59(3):364-71.)发表文章指出,研究显示单次测量基线蛋白尿易低估肾脏不良预后风险。       研究者在加拿大阿尔伯塔省开展纵向研究,测试入组成年人的蛋白尿水平(试纸测量)、计算尿白蛋白/肌酐比值(Alb

NDT:同步检测尿总蛋白和白蛋白有助于鉴别蛋白尿来源

    检测尿蛋白分子量有助于鉴别蛋白尿来源,尤其是区别肾小球性和肾小管性蛋白尿。最近有学者应用电泳法和免疫固定法检测了1011例患者的尿总蛋白/肌酐(uPCR)和尿白蛋白/肌酐(uACR),并计算尿白蛋白/总蛋白(uAPR),同时234例肾内科门诊患者应用检测尿肾小管蛋白标志物NAG和β-MG,并计算其与尿肌酐比值。       结果显示,计

Diabetes Care:高脉压差与蛋白尿相关性因人而异

  日本一项纳入22万余例受试者的研究发现,糖尿病、糖尿病前期和糖耐量正常者蛋白尿的发生率存在显著差异,仅糖尿病患者的高脉压差(独立于收缩压、舒张压和平均血压值)和蛋白尿显著相关。文献4月3日在线发表于《糖尿病护理》(Diabetes Care)杂志。    

Am J Cardiol: 蛋白尿可预测显著冠脉狭窄

    韩国学者的一项研究表明,在伴有亚临床动脉粥样硬化的2型糖尿病患者中,蛋白尿为显着冠脉狭窄的独立预测因素。论文于2012年8月1日在线发表于《美国心脏病学杂志》(Am J Cardiol)。    此项研究共纳入232例伴有亚临床动脉粥样硬化的2型糖尿病患者,并均进行多层螺旋CT冠脉造影。通过颈动脉内中膜厚度(IMT)或颈动脉斑块确

AIM:对无症状成人慢性肾脏病筛检证据不足

  据8月28日《内科学年鉴》杂志(Ann Intern Med. 2012 Aug 28.)发表的美国预防服务工作小组(USPSTF)的一项声明,为无症状慢性肾脏病(CKD)成人筛检的收益与伤害的证据还不足以建议进行例行性筛检。      许多组织对USPSTF提出将CKD筛检列为考虑之一,促使该工作小组回顾有关检测与早期治疗之各种议题的证据。      各领域的结果都还未定论。工作小组

CJASN:蛋白尿与糖尿病患者认知减退相关

美国一项研究表明,在肾小球滤过率(eGFR)正常的糖尿病患者中,持续性和进展性蛋白尿与认知功能减退具有相关性。论文近日在线发表于《美国肾脏病学会临床杂志》(Clin J Am Soc Nephrol)。 此项研究共纳入2977例基线eGFR正常的糖尿病患者(平均年龄62.5±5.8),并在基线、20和40个月时对其实施神经心理学测验。测验内容包括信息处理速